Abstract
Sporothrix schenckii sensu lato is currently recognized as a species complex with only Sporothrix brasiliensis, Sporothrix schenckii sensu stricto, Sporothrix globosa and Sporothrix pallida identified to cause disease in the cat. Feline sporotrichosis in Asia is mainly reported from Malaysia where a single clonal strain of clinical clade D, Sporothrix schenckii sensu stricto manifesting low susceptibility to major antifungal classes, has been identified as the agent of the disease. Sporothrix globosa has been identified to cause disease from a single cat in Japan while the specific species of agent has not been identified yet for the disease in Thailand. Despite efforts to elucidate and describe the pathogenicity of the agent and the disease it causes, the paucity of data highlights the need for further molecular epidemiological studies to characterize this fungus and the disease it causes in Asia. Its prognosis remains guarded to poor due to issues pertaining to cost, protracted treatment course, zoonotic potential and low susceptibility of some strains to antifungals.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Sporotrichosis is a subacute to chronic infection caused by Sporothrix schenckii complex that typically infects the cutaneous or sub-cutaneous tissues in humans and animals. This worldwide infection is found predominantly in tropical to sub-tropical areas. It is currently recognized as a species complex consisting of Sporothrix brasiliensis, Sporothrix schenckii sensu stricto, Sporothrix globosa and Sporothrix luriei, united on the fact that they are all able to express increased virulence towards mammals (clinical clade), compared with mildly pathogenic species such as Sporothrix mexicana and Sporothrix pallida that is commonly associated with the environment (environmental clade) [1]. In veterinary medicine, S. brasiliensis, S. s. sensu stricto, S. globosa and S. pallida have been documented to cause of disease in cats, while only S. brasiliensis has been incriminated to cause clinical sporotrichosis in dogs [2,3,4,5,6,7,8]. The disease is historically referred to as ‘Rose Gardeners disease’, as the most common route of infection is often traced to the inoculation of conidia into broken skin via contaminated soil or plants during horticultural activities. It is only in recent times that the focus shifted to inter-cat aggression in an urban environment as an important risk factor for disease and its subsequent propagation where it was found that cats are particularly susceptible to Sporothrix schenkii complex infection, and the disease manifestation is usually severe, unlike that which occurs in other animal species [5, 9,10,11,12]. As zoonotic transmission from cats to humans has been reported in increasing frequency in endemic areas, the understanding of the immunopathogenesis of the pathogen in the feline species and the management of cat population in an urban environment is essential to limit and prevent the further spread of this disease [9, 13,14,15]. In this mini-review, we briefly discuss the status of feline sporotrichosis in Asia, with a focus on Malaysia.
Epidemiology
S. brasiliensis, currently regionally restricted to Brazil and Argentina is characterised by its inherent thermotolerability which translates to its ability to cause local and systemic disease [16, 17]. This species has been identified as the main cause of feline sporotrichosis epidemics in Brazil, with S. s. sensu stricto isolated in lesser frequency [2, 9, 13]. In Malaysia, the initial observation of the increasingly important role cats played in Sporothrix transmission was first highlighted by Zamri-Saad in 1990, and it was 12 years later in 2012 that a retrospective study of 19 cases of human sporotrichosis confirmed the important role cats played in disease transmission [12, 18]. In this retrospective study, 13/19 (68.4%) of human patients could recall a preceding trauma before the onset of the cutaneous eruption, and of these 13 cases, 7 (53.8%) reported a history of a cat scratch or bite. In this case series, lymphocutaneous sporotrichosis was the predominant clinical form observed in 13 cases (68.4%) [12]. Currently, a clonal strain from clinical clade D of S. s. sensu stricto is the only species causing feline sporotrichosis in Malaysia elucidated by sequence analyses of the calmodulin gene and of the ITS region [19]. This clonal strain of S. s. sensu stricto clinical clade D from Malaysia, instead of the more commonly isolated clinical clade C in Asia as reported by Zhou et al., suggests that the species is constantly evolving with the ability to undergo a process of purifying selection and subsequent population expansion, dependent on local environmental or host selection pressure. This clonal strain has been identified to be of the same strain which causes sporotrichosis in human patients and is the third most common cause of death in cats undergoing post-mortem in a teaching veterinary hospital where 104 out of 866 post-mortem cases (12%) were attributed by sporotrichosis [20, 21]. Recent clinical case reports of the first feline sporotrichosis from Bangkok, Thailand, and Kartanaka, India, have been reported [22, 23]. However, no speciation nor minimum inhibitory concentration studies were done to ascertain if it is the same clonal strain from Malaysia. Although S. globosa is the most common cause of human sporotrichosis in East Asia, only one documented case of S. globosa-causing disease in a cat has been recorded from Chiba prefecture in Japan, while S. pallida has been identified as an atypical cause of sporotrichosis in a cat from Australia [4, 7]. This paucity of data highlights the need for further molecular epidemiological studies to characterize this fungus and the disease it causes in Asia.
Clinical findings
Feline sporotrichosis occurs most commonly in young adult, free roaming and intact male cats associated with inter-animal aggression with no known breed predisposition. Chronic non-healing ulcers either localized or generalized with granulomatous nodules and crusts are commonly found on the head especially at the bridge of the nose, ear tips, distal limbs or tail base region, typifies the infection in cats. There is a preponderance of lesions to accrue at cooler regions of the host body such as at the nasal passages and especially at the ear tips in cats with sporotrichosis in Malaysia. (Figures 1, 2, 3 and 4) The preponderance of lesions to aggregate at these cooler sites, especially at the ear tips, may be due to the lack of thermotolerability of S. s. sensu stricto and S. globosa isolates compared with S. brasiliensis which has the propensity to disseminate in a susceptible feline host [24,25,26] (Fig. 5). This clinical finding is consistent with thermotolerability studies done on feline isolates of S. s. sensu stricto from Malaysia where up to 82% of isolates were not thermotolerant [3]. If nasal passages are affected, extracutaneous signs such as sneezing, dyspnoea and respiratory distress are commonly reported in tandem with cutaneous manifestations [24, 25].
Fatal disseminated form of the disease is associated S. brasiliensis infection which has not been reported in Asia, while co-infections with either feline immunodeficiency virus (FIV) or feline leukaemia virus (FeLV) has no significant effect on the final clinical manifestations or the prognosis of the disease in the feline patient [27]. In the human patient, clinical signs of sporotrichosis may be further classified into 3 forms—fixed cutaneous, lymphocutaneous and disseminated forms, and the extent of which form manifests is attributed to the pathogenicity of the infection species and the status of host immunity. However, such clear and distinct categorisation of clinical forms is not applicable on the feline patient and thus seldom used to describe clinical disease in this species. Recently, secondary screwworm myiasis on skin lesions caused by Sporothrix spp. lesions has been reported from Malaysia which further complicates the diagnosis for the veterinarian [28].
Diagnosis
Definitive diagnosis of sporotrichosis requires the isolation, identification plus phase transition of agent in culture and its species identification by morphologic studies and physiologic phenotyping, as well as polymerase chain reaction targeting the calmodulin gene [2, 5, 29, 30].
Colony morphology
At 25–30 °C, the fungi exist in its mycelial form and are seen as small and white or pale orange to orange-grey colonies with no cottony aerial hyphae. Some colonies are however black from the onset (Fig. 6a). Later, it is moist, wrinkled, leathery or velvety with narrow white border. At 35–37 °C, yeast colonies are cream or tan, smooth and yeast-like (Fig. 6b) [29].
Cytologic findings
The yeasts are found in abundance from impression smears taken from the feline patient where they are located intra and extracellularly, in pleomorphic shapes ranging from the classical cigar-shaped to round or oval yeast, measuring 3–5 μm in diameter with a thin, clear halo around a pale blue cytoplasm (Fig. 7) [31]. The sensitivity of cytology to detect sporothrix yeast in the feline patient is estimated to range from 79 to 84.9% [32, 33].
Pathologic findings
Diffuse pyogranulomatous inflammation with large foci of necrosis is seen throughout the superficial and deep dermis which may even extend to the deeper subcutis. Round to cigar-shaped organism, 3–10 μm in length to 1–2 μm in diameter, is seen both free and within macrophages. Commonly, organisms in cytoplasm of macrophages create large clear pockets full of yeast due to poorly visualized yeast cell wall [34] (Figs. 8 and 9). Other than routine haematoxylin-eosin stain (H & E), periodic acid Schiff (PAS) or Gomori’s methenamine silver (GMS) stain may also be utilized to visualize yeast organism on histological preparation. Other diagnostic techniques such as serology (enzyme-linked immunosorbent assay, ELISA) and polymerase chain reaction may also be utilised for diagnosis [35, 36].
Differential diagnoses include foreign body reactions (if organisms are not easily seen), histoplasmosis, cryptococcosis, feline herpes virus, squamous cell carcinoma and mycobacterial infection (Figs. 10 and 11). Diagnosis is straightforward as Sporothrix spp. organisms are numerous and readily identified on cytological preparation especially from the feline patient. Due to this characteristic, routine in-clinic cytology with Romanowsky-type stain and/or histopathology is the preferred diagnostic option for private veterinarians in Malaysia for a quick diagnosis. Yeast cells of Cryptococcus spp. are larger with a clear unstained zone of thick lipid capsule, while those of histoplasmosis and sporotrichosis are similar in size and distribution; typical cigar-shaped, slightly larger organisms of sporotrichosis and the increased prevalence of this infection in cats should allow separation [31, 34]. Confirmatory diagnosis for squamous cell carcinoma will require histopathology while those of herpes virus may require histopathology, polymerase chain reaction, virus isolation or immunohistochemistry (Fig. 12). In the case of mycobacterial infection, the cutaneous lesions are comprised of single or multiple ulcers, abscesses, plaques and nodules (Fig. 13). Infections by M. microti, just like Sporothrix spp., are predisposed to adult, male cats with no breed predisposition. On cytology, the organism is rod-shaped, refractile and non-staining on routine Romanowsky stains. Acid-fast stains such as Ziehl-Neelsen are needed to positively highlight the organism, and differentiation between mycobacterial species requires culture or polymerase chain reaction (PCR). Currently, due to the lack of accessibility to dedicated veterinary mycological/bacteriological laboratories in Asia and issues pertaining to cost, more specialized test such as molecular diagnostics, fungal culture and susceptibility testing remains out of reach for the veterinarian and pet owners to be assimilated as part of clinical diagnostic work-up. Of the four countries in Asia with reported feline sporotrichosis (India, Thailand, Malaysia and Japan), molecular and susceptibility studies have been reported from Malaysia and Japan.
Treatment and antifungal susceptibility
Treatment of feline sporotrichosis requires several weeks to months and must be continued for at least 1 month beyond clinical cure which translates to high cost of treatment, high risk of therapeutic adverse reactions and high risk of zoonotic transmission, and with the existence of lowly susceptible strains, feline sporotrichosis carries a guarded to poor prognosis. Despite a protracted treatment course, it is current understanding that the fungus does not develop resistance de novo [3]. Currently, potassium iodide, azoles (ketoconazole and itraconazole), amphotericin B, terbinafine, local heat therapy, cryosurgery and surgical resection have been documented as treatment options in the feline patient.
Potassium iodide has traditionally been the treatment for sporotrichosis despite that its exact mechanism of antifungal property remains poorly understood. It has been documented to inhibit neutrophil chemotaxis in peripheral blood, and despite its inability to increase monocyte or neutrophil killing of S. schenckii, potassium iodide induces cell degeneration, when the yeast is dipped in various concentration of iodide [37]. Potassium iodide either in its saturated form (saturated salt of potassium iodide, SSKI) or in its powder form re-packaged into capsules has been described to treat sporotrichosis at dosages that ranges from 2.5 to 20 mg/kg every 24 h in the feline patient [38, 39]. The powder form re-packaged into capsules is favoured over SSKI due to the latter’s tendency to be bitter which may cause hypersalivation, especially in the feline patient. From a report of 48 cases of cats receiving potassium iodide, 23 (47.9%) patients achieved clinical cure with treatment failure in 18 cats (37.5%), two reported deaths (4.2%) and treatment period averaging from four to 5 months. Common observed adverse reactions were hyporexia, lethargy, weight loss, vomiting and diarrhoea plus an increase in the liver enzyme alanine transaminase. No signs of iodism (lacrimation, salivation, coughing, facial swelling, tachycardia) nor thyroid hormone abnormalities were observed in this study [38]. However, due to its low cost, sodium or potassium iodide is still often used either singularly or in conjunction with azole antifungals to treat sporotrichosis [24, 38,39,40].
Azoles, such as ketoconazole and itraconazole, currently constitute the cornerstone therapy for sporotrichosis in companion animals, especially in the cat and dog where the antifungal inhibits the synthesis of ergosterol in cell wall of Sporothrix schenckii sensu lato. Itraconazoles’ anti-inflammatory and immunomodulatory capabilities are well documented, where it inhibits neutrophil chemotaxis and movement and reduces eosinophilic airway inflammation, and suppression of T lymphocytes has allowed itraconazole to be incorporated for the treatment of numerous human conditions such as palmoplantar pustulosis, allergic bronchopulmonary aspergillosis and mycosis fungoides [41, 42]. In veterinary medicine, itraconazole is favoured over ketoconazole as the latter is commonly associated with higher rate of adverse reactions such a vomiting, hepatic dysfunction and altered cortisol metabolism. Itraconazole at 5–10 mg/kg has been used successfully to treat feline sporotrichosis, with maximum plasma concentration of 0.7 ± 0.14 mg/L achieved with a 5-mg/kg oral dosing in the cat [43]. Based on the updated Clinical and Laboratory Standards Institute (CLSI) reference method for broth dilution antifungal susceptibility testing of filamentous fungi document M38-A2, the minimum inhibitory concentration (MIC) of S. brasiliensis, S. s. sensu stricto, S. globosa and S. pallida isolates from humans, canines and felines to various commonly used antifungals is presented in Table 1 [3, 7, 8, 44,45,46,47,48,49]. When compared between species, it would suggest that S. brasiliensis and S. s. sensu stricto are more susceptible to itraconazole and ketoconazole, whereas S. globosa, S. luriei and S. pallida display low susceptibility towards these antifungal agents. A common observation among attending veterinarians in Malaysia treating feline sporotrichosis is the observation of cases refractory to treatment with itraconazole and observations such as these are validated by the existence of isolates with MIC towards itraconazole > 4 mg/L which is the putative breakpoint for this fungus [3, 39]. Recently, higher dosages of itraconazole and/or its combination with other antifungals has been explored to treat these refractory cases but this increases the risk of adverse reactions on the feline patient when exposed to high dosages of antifungal drugs for such a protracted period of time [39, 50, 51]. When MIC’s are compared between species and different geographical regions, the lowly susceptible clonal strain of S. s. sensu stricto found in Malaysia compared with other parts of the world is apparent. Despite not being thermotolerant and its inability to cause systemic spread, the lowly susceptibility of the clonal strain in Malaysia towards commonly used veterinary antifungals severely limits the options available to the veterinarian to treat this disease. It can be surmised that Sporothrix schenckii sensu lato generally displays low susceptibility towards fluconazole, voriconazole and caspofungin but is sensitive to a varying degree to itraconazole, ketoconazole and clotrimazole, a common antifungal agent incorporated in many veterinary-medicated shampoo, sprays and mousses [52]. This suggest that topical application containing clotrimazole should be considered for the patient on top of systemic medication. Results from Table 1 also suggest that while S. brasiliensis may be the most virulent species for mammals due to its thermotolerability, less inherently virulent, non-thermotolerant species such as S. globosa, S. luriei and S. pallida exhibits low susceptibility to many antifungal classes compared with S. brasiliensis, which presents a different set of problems when attempting to treat infections from these species.
Terbinafine, a fungicide allylamine which inhibits the synthesis of ergosterol in the Sporothrix schenckii spp. cell wall, is another systemic antifungal therapeutic option for felines with sporotrichosis. Although it is not yet registered for the use in companion animals, terbinafine at the dosage of 30–40 mg/kg administered once a day has been utilized for the treatment of feline sporotrichosis [24]. Despite reports of successful treatment of human and canine sporotrichosis with terbinafine, its success in its incorporation for the treatment for feline sporotrichosis is still inconclusive [53]. The recent description of the protective effects of pyomelanin and eumelanin, both pigments synthesized by S. brasiliensis and S. s. sensu stricto that serves to protect the fungi against the antifungal terbinafine, may partially explain the reason why in vitro results may not necessarily correlates with in vivo response when patients were treated with this antifungal [54]. Results in Table 1 suggest that S. brasiliensis and S. globosa display susceptibility towards terbinafine but not for S. s. sensu stricto isolates particularly from Malaysia and S. globosa from Iran.
The application of amphotericin B has also been met with issues of toxicity, high cost and adverse reactions such as localized sterile abscess formation from intralesional injections [55]. Intralesional injections of amphotericin B with concurrent oral itraconazole for the treatment of sporotrichosis in cats has been described in a few publications. In a review of 26 cats with sporotrichosis treated with amphotericin B and oral itraconazole, 72.7% achieved clinical cure but only to recur in 27.3% of these patients [55, 56]. Current susceptibility studies suggest that Sporothrix spp. generally displays low susceptibility towards this antifungal and only intralesional injections would be able to achieve the MIC required to supress the growth of this fungus. Localized heat therapy is used as the fungus does not grow at temperature above 40 °C. This treatment modality has been met with issues of practicality and perhaps welfare concerns in its application on cats. As it is impossible to convince an animal patient to remain still for extended period of time for localized heat therapy to work, and it is also inhumane to expose patients to extreme heat, and thus, heat therapy has not been pursued as a viable treatment option in the cat [57, 58]. Cryosurgery, used in conjunction with itraconazole, has been used successfully to treat and cure 11 of 13 cats with sporotrichosis, with treatment lasting 3–16 months and a median of 8 months [59]. Surgical resection is possible for localized singular lesions but practical for generalized, disseminated forms [24].
During treatment follow-up reviews, it is imperative that the persistence of granuloma, especially those in the ear pinnae of cats, is assessed. As these resolving granulomas are visually and tactile wise indistinguishable to normal adjacent healthy tissue under normal room lighting, these granulomas may be better visualized when held against a bright light source. Any premature cessation of antifungal therapy before the complete resolution of granuloma will certainly lead to a relapse of disease. It is also not uncommon for ear tips to suffer from post-healing deformity which may jeopardise the aesthetic appearance of the patient (Fig. 14). Treatment is continued for 1 month beyond the resolution of all skin lesions and granulomas before a declaration of mycological cure. In a recent survey of 104 veterinarians in Malaysia, up to 12% of veterinarians in this survey have personally been infected with Sporothrix spp., with 58% of them observing clinical lesions suggestive of sporotrichosis on the owners of cats with the same disease (Han, unpublished data). Thus, it is also not surprising that the risk of zoonotic transmission was the most significant factor the veterinarian considers during treatment and the reason why some veterinarians may have reservations when presented with a cat with lesions suggestive of sporotrichosis. This highlights the importance of continuing education among veterinarians in order to reinforce personal hygiene and preventative measures in order to prevent zoonotic transmission.
Conclusion
The prognosis of feline sporotrichosis in Malaysia and by extension, Asia, remains guarded to poor due to persistent issues of cost, protracted time to treat, risk of zoonotic transmission and potential adverse reactions of antifungals when administered on a long-term basis. Not only in terms of the risk of zoonotic transmission, the current repertoire of commonly used registered veterinary antifungals consists of only itraconazole which is inadequate to address the issue of low fungal susceptibility. Future resources could be allocated for a larger scale epidemiological study of feline and canine sporotrichosis in Asia or the establishment of a pan-Asia sporotrichosis research centre. Regular seminars and workshops for veterinarians and pet owners for disease prevention should also be encouraged to highlight the importance of cats as disease propagators and the importance of early neutering to reduce inter-animal aggression to prevent inter-cat transmission.
References
Zhou X, Rodrigues A, Feng P, Hoog GS (2013) Global ITS diversity in the Sporothrix schenckii complex. Fungal Divers 2013:1–13
Rodrigues AM, Teixeira MM, Hoog GS et al (2013) Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline Sporotrichosis outbreaks. PLoS Negl Trop Dis 7:e2281
Han HS, Kano R, Chen C, Noli C (2017) Comparisons of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats. Vet Dermatol 28:156–e32
Kano R, Tsui CKM, Hamelin RC, Anzawa K, Mochizuki T, Nishimoto K, Hiruma M, Kamata H, Hasegawa A (2015) The MAT1-1:MAT1-2 ratio of Sporothrix globosa isolates in Japan. Mycopathologia 179:81–86
Schubach TMP, Menezes RC, Wanke B (2012) Sporotrichosis. In: Greene CE (ed) Infectious diseases of the dog and cat, 4th edn. Saunders Elsevier, St. Louis, pp 645–650
Schubach TM, Schubach A, Okamoto T et al (2006) Canine sporotrichosis in Rio de Janeiro, Brazil: clinical presentation, laboratory diagnosis and therapeutic response in 44 cases (1998-2003). Med Mycol 44:87–92
Thomson J, Trott DJ, Malik R, Galgut B, McAllister MM, Nimmo J et al (2019) An atypical cause of sporotrichosis in a cat. Med Mycol Case Rep 23:72–76
Viana PG, Figueiredo ABF, Gremião IDF, de Miranda LHM, da Silva Antonio IM, Boechat JS, de Sá Machado AC, de Oliveira MME, Pereira SA (2018) Successful treatment of canine sporotrichosis with terbinafine: case reports and literature review. Mycopathologia 183:471–478
Schubach A, Schubach TM, Barros MB, Wanke B (2005) Cat-transmitted sporotrichosis, Rio de Janeiro, Brazil. Emerg Infect Dis 11:952–1,954
Rodrigues AM, Hoog GS, de Camargo ZP (2016) Sporothrix species causing outbreaks in animals and humans driven by animal–animal transmission. PLoSPathog 2:e1005638. https://doi.org/10.1371/journal.ppat.100
Gremião IDF, Miranda LHM, Reis EG, Rodrigues AM, Pereira AS (2017) Zoonotic epidemic of sporotrichosis: cat to human transmission. PLoS Pathog 13:1–7
Tang MM, Tang JJ, Gill P, Chang CC, Baba R (2012) Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia. Int J Dermatol 51:702–708
Montenegro H, Rodrigues AM, Dias MAG, da Silva EA, Bernardi F, de Camargo ZP (2014) Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo, Brazil. BMC Vet Res 10:269
Macêdo-Sales PA, Souto SRLS, Destefani CA, Lucena RP, Machado RLD, Pinto MR, Rodrigues AM, Lopes-Bezerra LM, Rocha EMS, Baptista ARS (2018) Domestic feline contribution in transmission of Sporothrix in Rio de Janeiro state, Brazil: a comparison between infected and non-infected populations. BMC Vet Res 14:19
Rodrigues AM, de Hoog GS, Zhang Y, de Camargo ZP (2014) Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species. Emerg Microbes Infect 3:e32. https://doi.org/10.1038/emi.2014.33
Etchecopaz AN, Lanza N, Toscanini MA, Devoto TB, Pola SJ, Daneri GL, Iovannitti CA, Cuestas ML (2019) Sporotrichosis caused by Sporothrix brasiliensis in Argentina: case report, molecular identification and in vitro susceptibility pattern to antifungal drugs. J Mycol Med 15:100908. https://doi.org/10.1016/j.mycmed.2019.100908
Córdoba S, Isla G, Szusz W, Vivot W, Hevia A, Davel G, Canteros CE (2018) Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses 61:441–448. https://doi.org/10.1111/myc.12760
Zamri-Saad M, Salmiyah TS, Jasni SM et al (1990) Feline sporotrichosis: an increasingly important zoonotic disease in Malaysia. Vet Rec 127:480
Kano R, Okubo M, Siew HH, Kamata H, Hasegawa A (2015) Molecular typing of Sporothrix schenckii isolates from cats in Malaysia. Mycoses 58:220–224
Rathiymaler M, Zamri-Saad M, Annas S (2017) Disease conditions in cats and dogs diagnosed at the post-mortem laboratory of the Faculty of Veterinary Medicine, Universiti Putra Malaysia between 2005 and 2015. Pertanika J Trop Agric Sci 40:389–398
Kamal Azam NK, Selvarajah GT, Santhanam J, Abdul Razak MF, Ginsapu SJ, James JE, Suetrong S (2019) Molecular epidemiology of Sporothrix schenckii isolates in Malaysia. Med Mycol. https://doi.org/10.1093/mmy/myz106
Duangkaew L, Yurayart C, Limsivilai O, Chen C, Kasorndorkbua C (2019) Cutaneous sporotrichosis in a stray cat from Thailand. Med Mycol Case Rep 23:46–49
Yegneswaran PP, Sripathi H, Bairy I, Lonikar V, Rao R, Prabhu S (2009) Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Kartanaka, India. Int J Dermatol 48:1198–1200
Gremião ID, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA (2015) Feline sporotrichosis: epidemiological and clinical aspects. Med Mycol 53:15–21
de Souza EW, Borba CM, Pereira SA, Gremião ID, Langohr IM, de Oliveira MME et al (2018) Clinical features, fungal load, coinfections, histological skin changes and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis. Sci Rep 8:9074
Boechat JS, Oliveira MME, Almeida-Paes R, Gremião ID, Machado AC, Oliveira RVC et al (2018) Feline sporotrichosis: associations between clinical-epidemiological profiles and phenotypic-genotypic characteristics of the etiological agents in the Rio de Janeiro epizootic area. Mem Inst Oswaldo Cruz 113:185–196
Schubach TM, Schubach A, Okamoto T, Barros MB, Figueiredo FB, Cuzzi T et al (2004) Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998–2001). J Am Vet Med Assoc 224:623–629
Han HS, Toh PY, Yoong HB, Loh HM, Tan LL, Ng YY (2018) Canine and feline cutaneous screw-worm myiasis in Malaysia: clinical aspects in 76 cases. Vet Dermatol 29:442–e148
Barros MB, Paes RA, Schubach AO (2011) Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev 24:633–654
Kwon-Chung KJ, Bennett EJ (1992) Dermatophytoses. Medical mycology. Lea & Febiger, Philadelphia, pp 702–729 816–826
Raskin RE (2010) Skin and subcutaneous tissue. In: Raskin RE, Meyer DJ (eds) Canine and feline cytology, 2nd edn. Saunders Elsevier, St. Louis, pp 41–44
Pereira SA, Menezes RC, Gremião ID, Silva JN, Honse Cde O, Figueiredo FB et al (2011) Sensitivity of cytopathological examination in the diagnosis of feline sporotrichosis. J Feline Med Surg 13:220–223
Jessica N, Sonia RL, Rodrigo C, Isabella DF, Tânia MP, Jeferson C, Anna BF, Sandro A (2015) Diagnostic accuracy assessment of cytopathological examination of feline sporotrichosis. Med Mycol 53:880–884
Gross TL, Ihrke PJ, Walder EJ, Affolter VK (2005) Infectious nodular and diffuse granulomatous and pyogranulomatous diseases of the dermis. In: Gross TL, Ihrke PJ, Walder EJ, Affolter VK (eds) Skin disease of the dog and cat, 2nd edn. Blackwell Science, Oxford, pp 298–301
Fernandes GF, Lopes-Bezerra LM, Bernardes-Engemann AR, Schubach TM, Dias MA, Pereira SA et al (2011) Serodiagnosis of sporotrichosis infection in cats by enzyme-linked immunosdorbent assay using a specific antigen, SsCBF, and crude exoantigens. Vet Microbiol 147:445–449
Kano R, Watanabe K, Murakami M, Yanai T, Hasegawa A (2005) Molecular diagnosis of feline sporotrichosis. Vet Rec 156:484–485
Sterling JB, Heymann WR (2000) Potassium iodide in dermatology: a 19th century drug for the 21st century-uses, pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 43:691–697
Reis EG, Gremião ID, Kitada AA, Rocha RF, Castro VP, Barros ML et al (2012) Potassium iodide capsule treatment of feline sporotrichosis. J Fel Med Surg 14:399–404
Reis ÉG, Schubach TM, Pereira SA, Silva JN, Carvalho BW, Quintana MB et al (2016) Association of itraconazole and potassium iodide in the treatment of feline sporotrichosis: a prospective study. Med Mycol 54:684–690
Crothers SL, White SD, Ihrke PJ, Affolter VK (2009) Sporotrichosis: a retrospective evaluation of 23 cases seen in northern California (1987-2007). Vet Dermatol 20:249–259
Wark PAB, Hensley MJ, Boyle MJ, Toneguzzi RC, Simpson JL, McElduff P et al (2003) Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 111:952–957
Tsai YC, Tsai TF (2019) Itraconazole in the treatment of nonfungal cutaneous diseases: a review. Dermatol Ther (Heidelb) 9:271–280
Liang C, Shan Q, Zhang J, Li W, Zhang X, Wang J et al (2016) Pharmacokinetics and bioavailability of itraconazole oral solution in cats. J Fel Med Surg 18:310–314
Brilhante RS, Rodrigues AM, Sidrim JJ, Rocha MF, Pereira SA, Gremião ID et al (2016) In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil. Med Mycol 54:275–279
Ottonelli Stopiglia CD, Magagnin CM, Castrillón MR, Mendes SD, Heidrich D, Valente P, Scroferneker ML (2014) Antifungal susceptibilities and identification of species of the Sporothrix schenckii complex isolated in Brazil. Med Mycol 52:56–64
Oliveira DC, Markus Lopes PG, Spader TB, Mahl CD, Tronco-Alves GR, Lara VM et al (2011) Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil. J Clin Microbiol 49:3047–3049
Mahmoudi S, Zaini F, Kordbacheh P, Safara M, Heidari M (2016) Sporothrix schenckii complex in Iran: molecular identification and antifungal susceptibility. Med Mycol 54:593–599
Morrison AS, Lockhart SR, Bromley JG, Kim JY, Burd EM (2013) An environmental Sporothrix as a cause of corneal ulcer. Med Mycol Case Rep 2:88–90
Vettorato R, Heidrich D, Fraga F, Ribeiro AC, Pagani DM, Timotheo C, Amaro TG, Vettorato G, Scroferneker ML (2018) Sporotrichosis by Sporothrix schenckii sensu stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo: case report. Med Mycol Case Reports 19:18–20
Han HS (2017) The current status of feline sporotrichosis in Malaysia. Med Mycol J 58E:E107–E113
da Rocha RFDB, Schubach TMP, Pereira SA, Dos Reis ÉG, Carvalho BW, Gremião IDF (2018 Nov) Refractory feline sporotrichosis treated with itraconazole combined with potassium iodide. J Small Anim Pract 59(11):720–721. https://doi.org/10.1111/jsap.12852
Ganini T, Borba-Santos LP, Rodgrigues AM, de Camargo ZP, Rozental S (2017) Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates. J Med Microbiol 66:1573–1580
Guterres KA, de Matos CB, Osório Lda G, Schuch ID, Cleff MB (2014) The use of (1-3) β-glucan along with itraconazole against canine refractory sporotrichosis. Mycopathologia 177:217–221
Almeida-Paes R, Figueiredo-Carvalho MHG, Brito-Santos F, Almeida-Silva F, Oliveira MME, Zancopé-Oliveira RM (2016) Melanins protect Sporothrix brasiliensis and Sporothrix schenckii from the antifungal effects of terbinafine. PLoS One 11:e0152796. https://doi.org/10.1371/journal.pone.0152796
Gremião IDF, Schubach TMP, Pereira SA, Rodrigues AM, Honse CO, Barros MBL (2011) Treatment of refractory feline sporotrichosis with a combination of intralesional amphotericin B and oral itraconazole. Aust Vet J 89:346–351
Gremião IDF, Schubach TMP, Pereira SA, Rodrigues AM, Chaves AR, Barros MBL (2009) Intralesional amphotericin B in a cat with refractory localised sporotrichosis. J Fel Med Surg 11:720–723
Doherty CB, Doherty SD, Rosen T (2010) Thermotherapy in dermatologic infections. J Am Acad Dermatol 62:909–927
Hiruma M, Kawada A, Noguchi H, Ishibashi A, Diaz IAC (1992) Hyperthermic treatment of sporotrichosis: experimental use of infrared and far infrared rays. Mycoses 35:11–12
de Souza CP, Lucas R, Ramadinha RH, Pires TB (2016) Cryosurgery in association with itraconazole for the treatment of feline sporotrichosis. J Feline Med Surg 18:137–143
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there are no conflict of interest.
Additional information
Responsible Editor: Sandro Rogerio de Almeida.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Han, H.S., Kano, R. Feline sporotrichosis in Asia. Braz J Microbiol 52, 125–134 (2021). https://doi.org/10.1007/s42770-020-00274-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42770-020-00274-5